Legend Biotech Corporation (LEGN)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS52490G1022
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Legend Biotech Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:12. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Mar 2027 08:00 | 0.07 | — | — | Upcoming |
| 10 Nov 2026 07:00 | 0.01 | 0.28 | +2,700.0% | Beat |
| 11 Aug 2026 07:00 | 0.28 | 0.32 | +14.3% | Beat |
| 10 Mar 2026 07:00 | -0.19 | -0.16 | +15.8% | Beat |
| 12 Nov 2025 07:00 | -0.18 | -0.22 | -18.9% | Miss |
| 11 Aug 2025 07:00 | -0.23 | -0.68 | -195.7% | Miss |
| 13 May 2025 07:00 | -0.34 | -0.54 | -61.6% | Miss |
| 11 Mar 2025 07:00 | -0.41 | 0.14 | +135.3% | Beat |
| 12 Nov 2024 07:00 | -0.60 | -0.68 | -12.8% | Miss |
| 09 Aug 2024 07:00 | -0.42 | -0.10 | +76.0% | Beat |
| 13 May 2024 07:00 | -0.32 | -0.32 | -0.4% | In line |
| 11 Mar 2024 07:00 | -0.91 | -0.80 | +11.8% | Beat |
| 20 Nov 2023 06:00 | -0.74 | -0.34 | +54.4% | Beat |
| 15 Aug 2023 06:00 | -0.83 | -1.14 | -37.3% | Miss |
| 18 May 2023 08:00 | -0.72 | -0.68 | +6.2% | Beat |
| 17 Feb 2023 07:00 | -0.56 | -0.82 | -46.1% | Miss |
| 03 Nov 2022 20:00 | -0.63 | -0.89 | -40.9% | Miss |
| 01 Jun 2022 08:00 | -0.51 | -0.49 | +3.5% | Beat |
| 18 Mar 2022 16:00 | 0.06 | -0.60 | -1,100.0% | Miss |
| 16 Nov 2021 08:00 | -0.66 | -0.86 | -30.3% | Miss |
| 23 Aug 2021 08:00 | -0.43 | -0.66 | -53.5% | Miss |
| 18 May 2021 08:00 | -0.45 | -0.60 | -33.3% | Miss |
| 18 Mar 2021 07:00 | -0.30 | -0.44 | -46.7% | Miss |
| 16 Nov 2020 07:00 | -0.34 | -0.50 | -47.1% | Miss |
| 28 Aug 2020 16:00 | -0.28 | -0.51 | -78.7% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1B | +64.0% | -296.8M | -28.8% | -1.62 | -68.8% | -128.8M |
| 2024 | 627.3M | +120.0% | -177M | -28.2% | -0.96 | +67.3% | -158.1M |
| 2023 | 285.1M | +143.7% | -518.3M | -181.8% | -2.94 | -5.0% | -416M |
| 2022 | 117M | — | -446.3M | -381.5% | -2.80 | — | -223.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 23.80 | 24.42 | 17.86 | 18.54 | -20.77% | 17,271,133 | |
| 02 Nov 2026 – 06 Nov 2026 | 21.78 | 23.98 | 20.99 | 23.40 | +8.18% | 10,929,100 | |
| 26 Oct 2026 – 30 Oct 2026 | 19.17 | 22.98 | 19.08 | 21.63 | +12.25% | 11,417,900 | |
| 19 Oct 2026 – 23 Oct 2026 | 18.55 | 19.29 | 18.00 | 19.27 | +4.27% | 6,769,000 | |
| 12 Oct 2026 – 16 Oct 2026 | 18.40 | 19.92 | 17.56 | 18.48 | -0.75% | 13,160,300 | |
| 05 Oct 2026 – 09 Oct 2026 | 18.50 | 19.25 | 17.92 | 18.62 | +0.27% | 8,215,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 18.80 | 20.00 | 18.40 | 18.57 | -2.83% | 11,397,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 17.95 | 19.69 | 17.81 | 19.11 | +8.52% | 10,758,500 | |
| 14 Sep 2026 – 18 Sep 2026 | 18.80 | 18.80 | 16.86 | 17.61 | -5.53% | 15,133,400 | |
| 08 Sep 2026 – 11 Sep 2026 | 21.63 | 21.97 | 18.61 | 18.64 | -13.38% | 9,053,600 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Is Legend Biotech (LEGN) Reasonable After CARVYKTI Sales Growth? (opens in a new tab) Simply Wall St. · 12 Nov 2026 03:14
- Legend Biotech's Carvykti Positioned to Sustain Growth Into 2027, RBC Capital Markets Says (opens in a new tab) MT Newswires · 11 Nov 2026 16:43
- Oppenheimer Maintains Perform on Legend Biotech, Lowers Price Target to $25 (opens in a new tab) Benzinga · 11 Nov 2026 13:59
- Morgan Stanley Maintains Overweight on Legend Biotech, Lowers Price Target to $43 (opens in a new tab) Benzinga · 11 Nov 2026 13:49
- Barclays Maintains Overweight on Legend Biotech, Lowers Price Target to $61 (opens in a new tab) Benzinga · 11 Nov 2026 11:22
- RBC Capital Maintains Outperform on Legend Biotech, Lowers Price Target to $50 (opens in a new tab) Benzinga · 11 Nov 2026 11:20
- Legend Biotech (LEGN) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 11 Nov 2026 03:31
- Legend Biotech Corp (LEGN) Q3 2026 Earnings Call Highlights: CARVYKTI Sales Jump 36% as ... (opens in a new tab) GuruFocus.com · 10 Nov 2026 21:05
- LEGN Stock On Track For Worst Day Ever As Investors Focus On Decelerating US Demand For CARVYKTI Therapy (opens in a new tab) Stocktwits · 10 Nov 2026 20:11
- What Legend Biotech (LEGN) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 10 Nov 2026 17:15
- Legend Biotech Corporation (LEGN) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 16:30
- Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights (opens in a new tab) 10 Nov 2026 12:00
- Legend Biotech Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 10:11
- Legend Biotech Q3 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $359.500M Miss $361.619M Estimate (opens in a new tab) Benzinga · 10 Nov 2026 08:01
- A $2 Billion Fund Bought These 3 Stocks Last Quarter (opens in a new tab) TIKR · 02 Nov 2026 10:40
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 19.54 USD
- Market cap
- 3.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow LEGN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.